Clarivate PLC

Clarivate Plc announced the appointment of Michael Easton as its new Executive Vice President & Chief Financial Officer, effective August 8, 2026, succeeding Jonathan Collins.

Clarivate Plc announced its second quarter 2026 financial results, reporting a net loss of $268.6 million, primarily due to a significant non-cash goodwill impairment charge, while reaffirming its full-year financial outlook.

Clarivate Plc announced a definitive agreement to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for $600 million.

Clarivate Plc has appointed former CPA Global CEO Simon Webster as President of its Intellectual Property segment, succeeding Maroun S. Mourad.

Clarivate Plc shareholders approved all proposals at the 2026 Annual General Meeting, including director elections and executive compensation.

Clarivate Plc announced its first quarter 2026 financial results, showing progress on its Value Creation Plan and reaffirming its full-year financial outlook.

Clarivate Plc announced its second quarter 2026 financial results, reporting a net loss and detailing the agreement to divest its Life Sciences & Healthcare business for $600 million.

Clarivate Plc reported a slight revenue decrease in Q1 2026 compared to the prior year, but saw an improvement in operating income and Adjusted EBITDA margin.

Clarivate Plc reported a reduced net loss for Q3 2025, with revenues remaining flat for the quarter but declining for the nine-month period, as the company continues its Value Creation Plan and debt optimization efforts.

Clarivate Plc reported a narrower net loss for the second quarter and first half of 2025, driven by the absence of prior-year goodwill impairment, despite a decline in overall revenues and free cash flow as the company continues its Value Creation Plan and product group wind-downs.

Clarivate Plc's Q1 2025 results reveal a revenue decrease primarily due to divestitures and wind-downs, despite growth in recurring revenue and cost management efforts.

Clarivate's Q3 2024 results show a revenue decrease and a net loss, impacted by restructuring, impairments, and divestitures.

Clarivate Plc reported a 4% revenue decline in 2025 to $2.46 billion, alongside a significantly reduced net loss and increased free cash flow, as it executes its Value Creation Plan focused on AI innovation and business streamlining.

Clarivate Plc's 2024 10-K filing reveals a year of strategic adjustments, including divestitures and cost rationalization, amidst a challenging macroeconomic environment impacting revenue and profitability.

Clarivate Plc's annual report on Form 10-K for 2023 details the company's financial results, internal control assessments, and future outlook.

Clarivate PLC Director Kenneth L. Cornick reported transactions involving ordinary shares, including an award and tax withholdings.

Andrew Snyder, a Director at Clarivate PLC, received a quarterly award of ordinary shares valued at $51,250, elected in lieu of a cash retainer.

Clarivate PLC President of IP, Simon Webster, acquired 396,825 ordinary shares as part of an equity compensation arrangement.

Director Wendell Pritchett acquired 62,264 restricted share units and disposed of 3,367 shares for tax withholding purposes.

Clarivate Plc director Jane Okun Bomba received an annual equity grant and settled tax obligations through share withholding.

Director Saurabh Saha reported the withholding of shares for taxes and the receipt of an annual restricted share unit award.

Clarivate PLC announced its 2026 Annual General Meeting agenda, including director re-elections and executive compensation approval, alongside a review of its 2025 financial performance which saw revenue decline but net loss improve.

Clarivate PLC's upcoming Annual General Meeting on May 7, 2025, will address director re-elections, executive compensation, auditor reappointment, an incentive award plan, and share repurchase authorization.

Clarivate PLC announces its 2025 Annual General Meeting (AGM) scheduled for May 7, 2025, in London, detailing proposals for shareholder voting including director re-elections, executive compensation approval, auditor ratification, incentive plan approval, and share repurchase authorization.

Clarivate PLC's 2024 Annual General Meeting will be held on May 7, 2024, with shareholders voting on the election of directors, executive compensation, and the ratification of independent auditors.

Clarivate Plc will hold its 2024 Annual General Meeting of Shareholders on May 7, 2024, to vote on director elections, executive compensation, and the ratification of its independent auditor.

Impactive Capital and its affiliates have significantly reduced their beneficial ownership in Clarivate PLC, selling over 15.8 million shares in the past 60 days.

Clarkston Capital Partners, LLC and affiliated entities have jointly filed a Schedule 13G/A, reporting beneficial ownership of 6.70% of Clarivate PLC's ordinary shares as of March 31, 2026.

Investment firm Baupost Group, along with its affiliates and founder Seth A. Klarman, has disclosed a beneficial ownership of 1.58% in Clarivate PLC, totaling 10,777,863 common shares.